Literature DB >> 24932151

Intensive sleep deprivation and cognitive behavioral therapy for pharmacotherapy refractory insomnia in a hospitalized patient.

Joshua Breitstein1, Brandon Penix2, Bernard J Roth3, Tristin Baxter3, Vincent Mysliwiec3.   

Abstract

The case of a 59-year-old woman psychiatrically hospitalized with comorbid insomnia, suicidal ideation, and generalized anxiety disorder is presented. Pharmacologic therapies were unsuccessful for treating insomnia prior to and during hospitalization. Intensive sleep deprivation was initiated for 40 consecutive hours followed by a recovery sleep period of 8 hours. Traditional components of cognitive behavioral therapy for insomnia (CBTi), sleep restriction, and stimulus control therapies, were initiated on the ward. After two consecutive nights with improved sleep, anxiety, and absence of suicidal ideation, the patient was discharged. She was followed in the sleep clinic for two months engaging in CBTi. Treatment resulted in substantial improvement in her insomnia, daytime sleepiness, and anxiety about sleep. Sleep deprivation regimens followed by a restricted sleep recovery period have shown antidepressant effects in depressed patients. Similar treatment protocols have not been investigated in patients with pharmacotherapy refractory insomnia and generalized anxiety disorder.

Entities:  

Keywords:  anxiety; depression; hypnotics; insomnia; sleep deprivation; sleep restriction therapy

Mesh:

Substances:

Year:  2014        PMID: 24932151      PMCID: PMC4031412          DOI: 10.5664/jcsm.3804

Source DB:  PubMed          Journal:  J Clin Sleep Med        ISSN: 1550-9389            Impact factor:   4.062


  9 in total

Review 1.  Sleep deprivation therapy.

Authors:  H Kuhs; R Tölle
Journal:  Biol Psychiatry       Date:  1991-06-01       Impact factor: 13.382

2.  Sleep restriction for the inpatient treatment of insomnia.

Authors:  C M Morin; R A Kowatch; G O'Shanick
Journal:  Sleep       Date:  1990-04       Impact factor: 5.849

3.  Cognitive behavioral therapy vs zopiclone for treatment of chronic primary insomnia in older adults: a randomized controlled trial.

Authors:  Børge Sivertsen; Siri Omvik; Ståle Pallesen; Bjørn Bjorvatn; Odd E Havik; Gerd Kvale; Geir Høstmark Nielsen; Inger Hilde Nordhus
Journal:  JAMA       Date:  2006-06-28       Impact factor: 56.272

4.  A randomized controlled trial of intensive sleep retraining (ISR): a brief conditioning treatment for chronic insomnia.

Authors:  Jodie Harris; Leon Lack; Kristyn Kemp; Helen Wright; Richard Bootzin
Journal:  Sleep       Date:  2012-01-01       Impact factor: 5.849

5.  Sleep deprivation therapy in depression syndromes.

Authors:  D King
Journal:  Psychosomatics       Date:  1980-05       Impact factor: 2.386

6.  Epidemiology of insomnia, depression, and anxiety.

Authors:  Daniel J Taylor; Kenneth L Lichstein; H Heith Durrence; Brant W Reidel; Andrew J Bush
Journal:  Sleep       Date:  2005-11       Impact factor: 5.849

7.  Sleep restriction therapy and hypnotic withdrawal versus sleep hygiene education in hypnotic using patients with insomnia.

Authors:  Daniel J Taylor; Wolfgang Schmidt-Nowara; Carol A Jessop; John Ahearn
Journal:  J Clin Sleep Med       Date:  2010-04-15       Impact factor: 4.062

Review 8.  Pathological and therapeutic consequences of sleep loss: a review.

Authors:  D King
Journal:  Dis Nerv Syst       Date:  1977-11

9.  Partial sleep deprivation as therapy for depression.

Authors:  B Schilgen; R Tölle
Journal:  Arch Gen Psychiatry       Date:  1980-03
  9 in total
  3 in total

1.  Ketamine-Induced Glutamatergic Mechanisms of Sleep and Wakefulness: Insights for Developing Novel Treatments for Disturbed Sleep and Mood.

Authors:  Wallace C Duncan; Elizabeth D Ballard; Carlos A Zarate
Journal:  Handb Exp Pharmacol       Date:  2019

2.  Validity and reliability of sleep promotion questionnaire and predictors of quality of care.

Authors:  Son Chae Kim; Chase Pedersen; Cassia Yi
Journal:  SAGE Open Med       Date:  2018-08-16

3.  Stabilising sleep for patients admitted at acute crisis to a psychiatric hospital (OWLS): an assessor-blind pilot randomised controlled trial.

Authors:  Bryony Sheaves; Daniel Freeman; Louise Isham; Josephine McInerney; Alecia Nickless; Ly-Mee Yu; Stephanie Rek; Jonathan Bradley; Sarah Reeve; Caroline Attard; Colin A Espie; Russell Foster; Anna Wirz-Justice; Eleanor Chadwick; Alvaro Barrera
Journal:  Psychol Med       Date:  2017-11-07       Impact factor: 7.723

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.